BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

9 articles for AK Sharma

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.EBI
Penn State Hershey Cancer Institute
Appraisal of GABA and PABA as linker: design and synthesis of novel benzamide based histone deacetylase inhibitors.EBI
Guru Ghasidas University
Development of a sphingosine kinase 1 specific small-molecule inhibitor.EBI
Pennsylvania State University College of Medicine
Fyn, Blk, and Lyn kinase inhibitors: A mini-review on medicinal attributes, research progress, and future insights.EBI
ISF College of Pharmacy
Development of a specific and potent IGF2BP1 inhibitor: A promising therapeutic agent for IGF2BP1-expressing cancers.EBI
Pennsylvania State University
Selenization of Small Molecule Drugs: A New Player on the Board.EBI
University of Navarra
Molecular editing of EBI
National Institute of Pharmaceutical Education and Research (NIPER)
ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.EBI
University of Florida
Development and Therapeutic Potential of Selenazo Compounds.EBI
Universidad De Navarra